Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ballester (Burjassot (Valencia), Spain). Role of MUC1 in idiopathic pulmonary fibrosis: mechanistic insights. 4889

Member's Comments

No comment yet.

Related content which might interest you: Role of MUC4 in idiopathic pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Role of MUC4 in idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 Living well with pulmonary fibrosis: new insights Source: Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway Year: 2021 Role of MUC1 in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Combined idiopathic pulmonary fibrosis and emphysema: functional characterization Source: Eur Respir J 2004; 24: Suppl. 48, 283s Year: 2004 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Stress failure and high-altitude pulmonary oedema: mechanistic insights from physiology Source: Eur Respir J 2010; 35: 470-472 Year: 2010 Epithelial pIgR: A new player in idiopathic pulmonary fibrosis? Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Insights into idiopathic pulmonary fibrosis in the real world Source: Eur Respir J 2015; 46: 16-18 Year: 2015 SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021 The genetic basis of idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1717-1727 Year: 2015 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Role of the inflammasome in idiopathic pulmonary fibrosis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017